GSK Says Canadian Court Dismissed Zantac Litigation GSK Says Canadian Court Dismissed Zantac Litigation
The British Columbia Supreme Court dismissed a proposed class action in Canada against heartburn drug Zantac over increased cancer risk, drugmaker GSK said on Friday.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news
More News: Canada Health | Cancer | Cancer & Oncology | Gastroenterology | Health | Heartburn | Legislation | UK Health